Projected Growth of the Global Small Molecule CMO/CDMO Market to Reach $72.9 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the small molecule cmo/cdmo market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Small Molecule CMO/CDMO Market By The End Of 2029?

The small molecule CMO/CDMO market has demonstrated robust expansion over recent years. Its valuation is forecast to climb from $50.58 billion in 2024 to $54.42 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.6%. This past growth can be ascribed to elements like supportive government policies, economical remedies, rising intricacy in drug formulation, sector integration, and a concentration on fundamental strengths.

The small molecule CMO/CDMO market is projected to experience substantial expansion over the coming years, anticipated to reach a value of $72.9 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 7.6%. This anticipated growth is attributed to factors such as an increase in drug development pipelines, the globalization of pharmaceutical activities, a rising demand for flexible manufacturing solutions, specialized expertise in regulatory adherence, and the ongoing convergence of biopharmaceutical sectors. Key developments expected during this period include the adoption of sustainable and environmentally friendly manufacturing practices, enhanced collaboration and partnerships, the advancement of personalized medicine and niche therapies, the emergence of virtual and virtual-to-reality companies, the integration of digital technologies, and efficient rapid response manufacturing capabilities.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13733&type=smp

Which Business Drivers Are Underpinning The Growth Of The Small Molecule CMO/CDMO Market?

The anticipated surge in pharmaceutical demand is set to boost the growth of the small-molecule CMO/CDMO market moving forward. The pharmaceutical industry encompasses the discovery, development, and manufacturing of drugs and medicines by both public and private entities. Small-molecule CMO/CDMO services are employed in this industry to outsource a range of functions, including the development, production, and packaging of small-molecule drugs, which assists pharmaceutical companies in reducing costs, saving time, and optimizing processes. For example, in August 2024, according to the Government of Canada, a Canada-based government agency, domestic pharmaceutical exports reached 9.59 billion USD (12.79 billion CAD) in 2022, an increase from 10.71 billion CAD in 2021. Imports also saw a rise, reaching 30.21 billion CAD compared to 26.63 billion CAD in 2021. Therefore, the increasing need for pharmaceuticals is acting as a key driver for the expansion of the small-molecule CMO/CDMO market.

What Are The Principal Segment Types In The Small Molecule CMO/CDMO Market?

The small molecule cmo/cdmo market covered in this report is segmented –

1) By Product: Small Molecule Drug Product, Small Molecule API

2) By Stage Type: Clinical, Commercial, Preclinical

3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics

4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders

Subsegments:

1) By Small Molecule Drug Product: Solid Dosage Forms (Tablets, Capsules), Liquid Dosage Forms (Injectables, Solutions), Topical Dosage Forms

2) By Small Molecule API (Active Pharmaceutical Ingredient): Generic APIs, Branded APIs, Custom Synthesis APIs

How Are Industry Trends Steering The Expansion Of The Small Molecule CMO/CDMO Market?

Major companies within the small-molecule CMO/CDMO market are concentrating on innovative technologies, such as the sophisticated small-molecule platform located in Shanghai, to elevate their CDMO services. This type of advanced small-molecule platform represents the forefront of technological advancements for developing and producing small-molecule drugs, with the goal of creating pharmaceutical compounds that are safer, more effective, and manufactured more efficiently. For instance, in June 2023, Porton Pharma Solutions Ltd., a pharmaceutical company based in China, launched a sophisticated small-molecule platform in Shanghai, thereby enhancing its CDMO services. A state-of-the-art small molecule platform embodies a comprehensive approach, combining cutting-edge technologies and methodologies to advance the entire lifecycle of small molecule pharmaceuticals, offering one-stop-shop solutions, an end-to-end platform, flexibility and availability, and digital transformation.

Which Companies Are Contributing Significantly To The Small Molecule CMO/CDMO Market Growth?

Major companies operating in the small molecule CMO/CDMO market report are Patheon NV (Thermo Fisher Scientific), GlaxoSmithKline, Johnson Matthey PLC, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc., Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Avid Bioservices Inc., Dishman Carbogen Amcis Ltd., ProChem Inc., Metrics Contract Services

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/small-molecule-cmo-or-cdmo-global-market-report

Which Region Offers The Most Opportunity For Small Molecule CMO/CDMO Market Expansion?

North America was the largest region in the small molecule CMO/CDMO market in 2024. The regions covered in the small molecule CMO/CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=13733&type=smp

Browse Through More Reports Similar to the Global Small Molecule CMO/CDMO Market 2025, By The Business Research Company

Non Therapeutic Biomolecules Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Small Molecule Api Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/small-molecule-api-global-market-report

Small Molecule Drug Discovery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795